NCT06796569 Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
| NCT ID | NCT06796569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Systemic Lupus Erythematosus |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-12-02 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2024-12-02 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the association between the systemic immune-inflammation index and disease activity, as well as lupus nephritis in patients with systemic lupus erythematosus
Eligibility Criteria
Inclusion Criteria: * o Older than 16 years * In a patient with SLE, patients who fulfill the criteria of the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR). * In patients with LN, patients whose diagnosis is confirmed by kidney biopsy and pathohistological verification (WHO classification, and the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification. Exclusion Criteria: * Patients with other autoimmune rheumatological diseases, lymphoproliferative disorders, malignancies, liver diseases, end-stage kidney disease, diabetic nephropathy, active infections, recent history of blood transfusion and patients with deficiencies in vitamin B12, folate, and iron are excluded from the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06796569 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Systemic Lupus Erythematosus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06796569 currently recruiting?
Yes, NCT06796569 is actively recruiting participants. Contact the research team at Shrouk011107@med.sohag.edu.eg for enrollment information.
Where is the NCT06796569 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06796569 clinical trial?
NCT06796569 is sponsored by Sohag University. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.